B Hooshmand

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. ncbi request reprint Vitamin d in relation to cognitive impairment, cerebrospinal fluid biomarkers, and brain volumes
    Babak Hooshmand
    Aging Research Center, KI Alzheimer s Disease Research Center, and
    J Gerontol A Biol Sci Med Sci 69:1132-8. 2014
  2. pmc Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy study
    Babak Hooshmand
    Ageing Research Centre, Department of Neurobiology, Care Sciences, and Society, Karolinska Institute, 11330 Stockholm, Sweden
    Brain 136:2707-16. 2013
  3. ncbi request reprint Associations between serum homocysteine, holotranscobalamin, folate and cognition in the elderly: a longitudinal study
    B Hooshmand
    Aging Research Center, KarolinskaInstitutet, Stockholm, Sweden
    J Intern Med 271:204-12. 2012
  4. doi request reprint Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study
    B Hooshmand
    Aging Research Center, Department of Neurobiology, Care Sciences and Society NVS, Karolinska Institutet, Gavlegatan 16, S 113 30, Stockholm, Sweden
    Neurology 75:1408-14. 2010

Detail Information

Publications4

  1. ncbi request reprint Vitamin d in relation to cognitive impairment, cerebrospinal fluid biomarkers, and brain volumes
    Babak Hooshmand
    Aging Research Center, KI Alzheimer s Disease Research Center, and
    J Gerontol A Biol Sci Med Sci 69:1132-8. 2014
    ..The objective of this study was to examine the relations between plasma 25-hydroxyvitamin D (25(OH)D) and cognitive impairment, CSF biomarkers of Alzheimer's disease (AD), and structural brain tissue volumes...
  2. pmc Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy study
    Babak Hooshmand
    Ageing Research Centre, Department of Neurobiology, Care Sciences, and Society, Karolinska Institute, 11330 Stockholm, Sweden
    Brain 136:2707-16. 2013
    ..This effect seems to be more pronounced in the presence of cerebrovascular pathology. Randomized controlled trials are needed to determine the impact of homocysteine-lowering treatments on dementia-related pathology. ..
  3. ncbi request reprint Associations between serum homocysteine, holotranscobalamin, folate and cognition in the elderly: a longitudinal study
    B Hooshmand
    Aging Research Center, KarolinskaInstitutet, Stockholm, Sweden
    J Intern Med 271:204-12. 2012
    ....
  4. doi request reprint Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study
    B Hooshmand
    Aging Research Center, Department of Neurobiology, Care Sciences and Society NVS, Karolinska Institutet, Gavlegatan 16, S 113 30, Stockholm, Sweden
    Neurology 75:1408-14. 2010
    ..To examine the relation between serum levels of homocysteine (tHcy) and holotranscobalamin (holoTC), the active fraction of vitamin B12, and risk of incident Alzheimer disease (AD) in a sample of Finnish community-dwelling elderly...